Skip to main content
. Author manuscript; available in PMC: 2019 Nov 14.
Published in final edited form as: Diagn Microbiol Infect Dis. 2011 Feb;69(2):145–152. doi: 10.1016/j.diagmicrobio.2010.10.021

Table 4.

Patient conditions and sample sources among discordant negative DFME and positive PCR resultsa

Patient no. n = 27 (%)
Primary patient medical condition
Hematologic malignancy and other hematologic disordersb 9 (33%)
Chronic lung disease with immunosuppressive drug therapyc 5 (19%)
Solid organ malignancyd 4 (15%)
Active connective tissue diseasee 4 (15%)
Kidney/pancreas transplantation 3 (11%)
HIV infection/AIDS 2 (7%)
Specimen source
BAL 18 (67%)
Induced sputum 6 (22%)
Tracheal secretions 2 (7%)
Lung tissue/biopsy 1 (4%)
a

Patients and samples from Mayo Clinic Rochester, MN. Note 2 of the 29 total patient samples with discordant test results from Table 3 are omitted as they were not patients at the Mayo Clinic and their records could not be reviewed.

b

Hematologic malignancies and other hematologic disorders: chronic lymphocytic leukemia (n = 3), multiple myeloma (n = 2), non-Hodgkin lymphoma (n = 1), Hodgkin disease (n = 1), acute myelogenous leukemia (n = 1), and aplastic anemia (n = 1).

c

Chronic lung disease with immunosuppressive therapy: interstitial lung disease (n = 2), bronchiolitis obliterans (n = 1), steroid-dependent asthma (n = 1) and idiopathic constrictive bronchiolitis (n = 1).

d

Solid organ malignancies: invasive breast carcinoma (n = 2), glioblastoma multiforme (n = 1), and recurrent pontine glioma (n = 1).

e

Active connective tissue diseases: Goodpasture disease (n = 2), rheumatoid arthritis (n = 1), and polymyalgia rheumatica (n = 1).